Company Data
Xilio Therapeutics Inc.
Ticker
XLO
Current Price
$8.88 -1.66%
Market Cap
$58.4M
Price Target
Refer to Report
Volume
55.7K
52wk Range
$6.4652 - $12.7386
Overview
Xilio Therapeutics Inc is a biotechnology company focused on harnessing the immune system to achieve deep and durable clinical responses to improve the lives of patients with cancer. Leveraging the GPS platform, they are building a pipeline of tumor-selective cytokine and checkpoint inhibitor immunotherapies to treat cancer. The goal is to overcome the limitations of current I-O therapies by developing products with an improved therapeutic index.